At the maternal–fetal interface, chorioamnionitis activates innate immune pathways in the placenta and membranes via TLR2/TLR4 recognition of Gram-positive or Gram-negative pathogen-associated molecular patterns (PAMPs), triggering the MyD88–NF-κB signaling cascade. This evidence concerns the gene NFKB1 and chorioamnionitis.